Aberdeen Group’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $168M | Buy |
423,324
+19,251
| +5% | +$8.41M | 0.24% | 70 |
|
|
2026
Q1 | $186M | Buy |
404,073
+23,565
| +6% | +$11.9M | 0.3% | 60 |
|
|
2025
Q4 | $216M | Sell |
380,508
-7,568
| -2% | -$4.03M | 0.33% | 50 |
|
|
2025
Q3 | $174M | Buy |
388,076
+62,446
| +19% | +$30M | 0.27% | 65 |
|
|
2025
Q2 | $177M | Buy |
325,630
+725
| +0.2% | +$379K | 0.3% | 61 |
|
|
2025
Q1 | $159M | Buy |
324,905
+97,721
| +43% | +$54M | 0.31% | 62 |
|
|
2024
Q4 | $119M | Sell |
227,184
-23,610
| -9% | -$12.3M | 0.22% | 96 |
|
|
2024
Q3 | $122M | Buy |
250,794
+4,240
| +2% | +$1.97M | 0.22% | 105 |
|
|
2024
Q2 | $110M | Sell |
246,554
-13,746
| -5% | -$5.47M | 0.21% | 109 |
|
|
2024
Q1 | $104M | Buy |
260,300
+406
| +0.2% | +$153K | 0.2% | 114 |
|
|
2023
Q4 | $87.7M | Buy |
259,894
+163,742
| +170% | +$48.8M | 0.19% | 125 |
|
|
2023
Q3 | $28.1M | Sell |
96,152
-3,466
| -3% | -$1.08M | 0.07% | 255 |
|
|
2023
Q2 | $34.1M | Sell |
99,618
-1,529
| -2% | -$463K | 0.08% | 236 |
|
|
2023
Q1 | $25.8M | Buy |
101,147
+349
| +0.3% | +$86K | 0.06% | 288 |
|
|
2022
Q4 | $26.7M | Buy |
100,798
+7,187
| +8% | +$1.75M | 0.07% | 283 |
|
|
2022
Q3 | $17.5M | Buy |
93,611
+1,217
| +1% | +$261K | 0.05% | 334 |
|
|
2022
Q2 | $18.6M | Sell |
92,394
-2,219
| -2% | -$521K | 0.06% | 300 |
|
|
2022
Q1 | $29.1M | Sell |
94,613
-20,978
| -18% | -$6.13M | 0.07% | 254 |
|
|
2021
Q4 | $41.5M | Sell |
115,591
-5,861
| -5% | -$2.02M | 0.09% | 223 |
|
|
2021
Q3 | $40.6M | Sell |
121,452
-1,038
| -0.8% | -$349K | 0.09% | 225 |
|
|
2021
Q2 | $37.6M | Sell |
122,490
-4,557
| -4% | -$1.28M | 0.08% | 232 |
|
|
2021
Q1 | $31.3M | Buy |
127,047
+7,818
| +7% | +$1.97M | 0.07% | 262 |
|
|
2020
Q4 | $32.5M | Buy |
119,229
+5,808
| +5% | +$1.44M | 0.08% | 226 |
|
|
2020
Q3 | $26.8M | Sell |
113,421
-14,592
| -11% | -$3.28M | 0.07% | 225 |
|
|
2020
Q2 | $24.3M | Sell |
128,013
-8,133
| -6% | -$1.46M | 0.07% | 257 |
|
|
2020
Q1 | $22.5M | Buy |
136,146
+4,209
| +3% | +$771K | 0.07% | 238 |
|
|
2019
Q4 | $26M | Sell |
131,937
-3,012
| -2% | -$564K | 0.06% | 281 |
|
|
2019
Q3 | $24.3M | Sell |
134,949
-654
| -0.5% | -$113K | 0.06% | 288 |
|
|
2019
Q2 | $23.7M | Sell |
135,603
-22,080
| -14% | -$3.78M | 0.05% | 329 |
|
|
2019
Q1 | $30M | Sell |
157,683
-16,716
| -10% | -$2.97M | 0.07% | 277 |
|
|
2018
Q4 | $27.3M | Sell |
174,399
-2,802
| -2% | -$475K | 0.06% | 274 |
|
|
2018
Q3 | $33.9M | Buy |
177,201
+9,024
| +5% | +$1.6M | 0.06% | 287 |
|
|
2018
Q2 | $26.8M | Buy |
168,177
+17,406
| +12% | +$2.65M | 0.05% | 329 |
|
|
2018
Q1 | $20.7M | Buy |
150,771
+1,626
| +1% | +$227K | 0.04% | 344 |
|
|
2017
Q4 | $18.1M | Buy |
149,145
+1,221
| +0.8% | +$153K | 0.03% | 369 |
|
|
2017
Q3 | $17.2M | Buy |
+147,924
| New | +$16.1M | 0.03% | 369 |
|
Other funds holding ISRG
Aberdeen Group's ISRG Position: Q2 2026 in Review
Aberdeen Group increased its Intuitive Surgical (ISRG) stake by 4.8% in Q2 2026, buying an estimated $8.41M and bringing the position to 423,324 shares worth $168M. The position accounts for 0.24% of the portfolio, ranked #70.
Aberdeen Group first reported a position in ISRG in Q3 2017 and has held it in 36 quarters since. The position peaked at $216M in Q4 2025. 2,244 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Aberdeen Group held 423,324 shares of Intuitive Surgical worth $168M as of Q2 2026.
- Aberdeen Group bought 19,251 Intuitive Surgical shares in Q2 2026, an estimated $8.41M.
- Intuitive Surgical made up 0.24% of Aberdeen Group's portfolio in Q2 2026, its #70 holding.
- Aberdeen Group first reported a position in Intuitive Surgical in Q3 2017 and has held it in 36 quarters since.
- Aberdeen Group's Intuitive Surgical position peaked at $216M in Q4 2025.
- 2,244 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.